Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2888316 | chr3:80514312 | G/C | 9.09E-5 | 172 | 19.87 | 24.03 | 25.67 | KM Plot |
PCPG | rs2897437 | chr13:48417974 | T/C | 5.94E-5 | 177 | 2.93 | 25.17 | 25.53 | KM Plot |
PCPG | rs2920022 | chr12:69040055 | G/A | 7.55E-8 | 176 | 14.4 | 27.82 | 23.53 | KM Plot |
PCPG | rs2930173 | chr3:53507195 | G/T | 0.000243 | 172 | 31.43 | 24.5 | 25.53 | KM Plot |
PCPG | rs2942806 | chr13:37654938 | A/G | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs2942807 | chr13:37654931 | T/G | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs2951825 | chr8:6726614 | T/G | 6.48E-10 | 176 | 27.3 | 18.7 | 8.2 | KM Plot |
PCPG | rs2951855 | chr8:6732698 | T/C | 7.25E-6 | 177 | 13.27 | 18.7 | 27.33 | KM Plot |
PCPG | rs2953168 | chr2:241539003 | A/G | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs2953171 | chr2:241536053 | C/T | 5.33E-5 | 172 | 25.97 | 21.82 | 10.3 | KM Plot |
PCPG | rs2974707 | chr5:141187233 | G/A | 0 | 178 | 15.08 | 32.02 | 24.52 | KM Plot |
PCPG | rs2975757 | chr2:241530616 | A/T | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs2975759 | chr2:241530793 | A/G | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs2975761 | chr2:241531584 | G/A | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs2977772 | chr8:6733196 | G/A | 8.59E-6 | 175 | 13.27 | 19 | 27.3 | KM Plot |